Today I’m talking with Harry Rowland, co-founder and CEO of Endotronix. Endotronix was founded in 2007 and is developing an implantable pressure sensor that can be placed in the pulmonary artery outside the heart.
Dr. Rowland has led the company’s innovation, strategy and technology developments since the project began and has raised millions of dollars in funding. In this episode, he shares the exciting new prospects this technology offers as part of a complete health system that provides tools and feedbacks to help extend and improve patient’s lives.
Dr. Rowland’s background in engineering and healthcare entrepreneurshipAdvanced heart failure, current standards of care and healthcare costsEndotronix implantable sensors and proactive heart disease managementRaising capital for the businessPerseverance and commitment as a startupFuture of Endotronix and clinical testingAdvice for new healthcare startupsEngaging both patients and clinicians to make the product successfulMedical device development in a global market
Learn more about your ad choices. Visit megaphone.fm/adchoices
Building a technology company is hard. Building one that serves the needs of consumers and works within the constraints of healthcare? …
Depression affects over 300 million people world-wide. In this episode, we dive into the work being done to develop personalized solutions …
Needs-based innovation with Marta Zanchi, PhD.
Marta is originally from Italy and spent 13 years at Stanford University, first …
What does pharma need to do to be successful with digital transformation? How do cultures get changed? Where do you start when managing …
Have you ever wondered how much more secure - or perhaps less secure - your organization is compared to your peers in the industry? This …
The topic: HIV
South Africa has the largest HIV epidemic in the world: 19% of the total number of people living with HIV, 15% of new infections and 11% of AIDS related deaths
South Africa …